• COVID-19
  • Biosimilars
  • Cataract Therapeutics
  • DME
  • Gene Therapy
  • Workplace
  • Ptosis
  • Optic Relief
  • Imaging
  • Geographic Atrophy
  • AMD
  • Presbyopia
  • Ocular Surface Disease
  • Practice Management
  • Pediatrics
  • Surgery
  • Therapeutics
  • Optometry
  • Retina
  • Cataract
  • Pharmacy
  • IOL
  • Dry Eye
  • Understanding Antibiotic Resistance
  • Refractive
  • Cornea
  • Glaucoma
  • OCT
  • Ocular Allergy
  • Clinical Diagnosis
  • Technology

Justine Smith begins term as new ARVO president

Article

Justine Smith, FRANZCO, PhD, FARVO, of Flinders University, Adelaide, South Australia, is the new president of the Association for Research in Vision and Ophthalmology.

Rockville, MD-Justine Smith, FRANZCO, PhD, FARVO, of Flinders University, Adelaide, South Australia, is the new president of the Association for Research in Vision and Ophthalmology (ARVO).

Dr. Smith succeeds Peng T. Khaw, MD, PhD, FARVO, of the Moorfields Eye Hospital and UCL Institute of Ophthalmology in England, whose 1-year term ended following the ARVO annual meeting earlier this month.

“It’s an honor to serve as president of this international group of leading and emerging leaders in eye and vision research,” Dr. Smith said. “I look forward to collaborating with our members in the coming year as we explore our efforts advancing areas as diverse as neuroscience, tissue imaging, and preventative medicine under the ARVO 2014 theme, ‘Leading Eye and Vision Research.’”

ARVO also announced its new vice presidents. They are John S. Penn, PhD, FARVO, of Vanderbilt University and David R. Williams, PhD, FARVO, of the University of Rochester.

William F. Mieler, MD, of the University of Illinois-Chicago is president-elect amd will serve the 2014-2015 term. Carol B. Toris, PhD, FARVO, of the University of Rochester is the vice president-elect for that term.

In addition, ARVO members elected two new trustees to its board. Serving a 5-year term are Sarah E. Coupland, MBBS, PhD, of the University of Liverpool, representing the Anatomy Pathology Section, and Claude F. Burgoyne, MD, FARVO, of the Devers Eye Institute/Legacy Research Institute, representing the Glaucoma Section. The new trustees began their terms after the 2013 annual meeting.

For more articles in this issue of Ophthalmology Times eReport, click here.

 

Related Videos
Paul Badawi, co-founder and CEO of Sight Sciences, chats with Neda Shamie, MD, about what drives him
© 2024 MJH Life Sciences

All rights reserved.